Clostridium butyricum is a butyrate-producing human gut symbiont that has been safely
used as a probiotic for decades. C. butyricum strains have been investigated for potential�…

Advances in gut microbiota research have triggered interest in developing colon butyrate
producers as niche-specific next-generation probiotics, targeted at increasing colon butyrate�…

Clostridium butyricum is a human commensal bacterium with beneficial effects including
butyrate production, spore formation, increasing levels of beneficial bacteria, and inhibition�…

The management of the dysbiosed gut microbiota in inflammatory bowel diseases (IBD) is
gaining more attention as a novel target to control this disease. Probiotic treatment with�…

As the major source of energy for colonic mucosal cells and as an important regulator of
gene expression, inflammation, differentiation, and apoptosis in host cells, microbiota�…

Gut-microbial butyrate is a short-chain fatty acid (SCFA) of significant physiological
importance than the other major SCFAs (acetate and propionate). Most butyrate producers�…

Butyrate is a short-chain fatty acid by-product of the microbial fermentation of dietary
fermentable materials in the large intestine; it is the main energy source for enterocyte�…

Butyrate has several beneficial properties that are essential to maintain gastrointestinal
health. Therefore butyrate-producing bacteria are seen as the next generation of probiotics�…

Microbiological treatments are expected to have a role in the future management of
inflammatory bowel disease (IBD). Clostridium butyricum (C. butyricum) is a probiotic�…

Obesity is associated with a cluster of metabolic disorders and systemic low-grade
inflammation involving multiple organs. Recent findings have suggested that intestine is a�…